These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
644 related items for PubMed ID: 9699642
41. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Decaudin D, Geley S, Hirsch T, Castedo M, Marchetti P, Macho A, Kofler R, Kroemer G. Cancer Res; 1997 Jan 01; 57(1):62-7. PubMed ID: 8988042 [Abstract] [Full Text] [Related]
42. Overexpression of HA-Bax but not Bcl-2 or Bcl-XL attenuates 6-hydroxydopamine-induced neuronal apoptosis. Oh JH, Choi WS, Kim JE, Seo JW, O'Malley KL, Oh YJ. Exp Neurol; 1998 Nov 01; 154(1):193-8. PubMed ID: 9875280 [Abstract] [Full Text] [Related]
43. Extremely low frequency magnetic fields and the promotion of H2O2-induced cell death in HL-60 cells. Ding GR, Nakahara T, Hirose H, Koyama S, Takashima Y, Miyakoshi J. Int J Radiat Biol; 2004 Apr 01; 80(4):317-24. PubMed ID: 15204708 [Abstract] [Full Text] [Related]
44. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB. Carcinogenesis; 2002 Jan 01; 23(1):143-50. PubMed ID: 11756235 [Abstract] [Full Text] [Related]
45. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460. Huisman C, Ferreira CG, Bröker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FA, Giaccone G. Clin Cancer Res; 2002 Feb 01; 8(2):596-606. PubMed ID: 11839682 [Abstract] [Full Text] [Related]
46. Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade. Shen SC, Chen YC, Hsu FL, Lee WR. J Cell Biochem; 2003 Aug 01; 89(5):1044-55. PubMed ID: 12874837 [Abstract] [Full Text] [Related]
47. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Dole MG, Jasty R, Cooper MJ, Thompson CB, Nuñez G, Castle VP. Cancer Res; 1995 Jun 15; 55(12):2576-82. PubMed ID: 7780971 [Abstract] [Full Text] [Related]
48. Bcl-xL overexpression restricts heat-induced apoptosis and influences hsp70, bcl-2, and Bax protein levels in FL5.12 cells. Robertson JD, Datta K, Kehrer JP. Biochem Biophys Res Commun; 1997 Dec 08; 241(1):164-8. PubMed ID: 9405251 [Abstract] [Full Text] [Related]
49. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities. Schmitt E, Cimoli G, Steyaert A, Bertrand R. Exp Cell Res; 1998 Apr 10; 240(1):107-21. PubMed ID: 9570926 [Abstract] [Full Text] [Related]
50. Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3. Amarante-Mendes GP, Naekyung Kim C, Liu L, Huang Y, Perkins CL, Green DR, Bhalla K. Blood; 1998 Mar 01; 91(5):1700-5. PubMed ID: 9473236 [Abstract] [Full Text] [Related]
51. Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells. Riordan FA, Bravery CA, Mengubas K, Ray N, Borthwick NJ, Akbar AN, Hart SM, Hoffbrand AV, Mehta AB, Wickremasinghe RG. Oncogene; 1998 Mar 26; 16(12):1533-42. PubMed ID: 9569020 [Abstract] [Full Text] [Related]
52. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD. Cell Growth Differ; 1996 May 26; 7(5):603-13. PubMed ID: 8732670 [Abstract] [Full Text] [Related]
53. Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells. Allouche M, Bettaieb A, Vindis C, Rousse A, Grignon C, Laurent G. Oncogene; 1997 Apr 17; 14(15):1837-45. PubMed ID: 9150390 [Abstract] [Full Text] [Related]
54. pIXY321 protects against Ara-C or taxol-induced apoptosis and loss of clonogenic survival of normal human bone marrow progenitor cells. Bhalla K, Ibrado AM, Bradt JE, Ray S, Huang Y, Tang C, Nawabi A, Hoffman R. Leukemia; 1995 Nov 17; 9(11):1851-6. PubMed ID: 7475274 [Abstract] [Full Text] [Related]
55. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Huang Y, Ibrado AM, Reed JC, Bullock G, Ray S, Tang C, Bhalla K. Leukemia; 1997 Feb 17; 11(2):253-7. PubMed ID: 9009089 [Abstract] [Full Text] [Related]
56. Apoptotic cell death induced by taxol is inhibited by nitric oxide in human leukemia HL-60 cells. Pae HO, Yoo JC, Choi BM, Kang CL, Kim JD, Chung HT. Immunopharmacol Immunotoxicol; 1999 Nov 17; 21(4):667-82. PubMed ID: 10584203 [Abstract] [Full Text] [Related]
57. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM. Cancer Res; 1996 Apr 15; 56(8):1851-4. PubMed ID: 8620503 [Abstract] [Full Text] [Related]
58. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB. EMBO J; 1997 Mar 03; 16(5):968-77. PubMed ID: 9118958 [Abstract] [Full Text] [Related]
59. Gossypol inhibits phosphorylation of Bcl-2 in human leukemia HL-60 cells. Huang LH, Hu JQ, Tao WQ, Li YH, Li GM, Xie PY, Liu XS, Jiang J. Eur J Pharmacol; 2010 Oct 25; 645(1-3):9-13. PubMed ID: 20633548 [Abstract] [Full Text] [Related]
60. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L). Perkins C, Kim CN, Fang G, Bhalla KN. Blood; 2000 Feb 01; 95(3):1014-22. PubMed ID: 10648417 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]